Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 GeneticVariation disease BEFREE Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1. 23018980 2013
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 Biomarker disease BEFREE However, the affected gene(s) responsible for primary hypoaldosteronism other than CYP11B2 remain to be determined. 22801770 2012
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 GeneticVariation disease BEFREE A case of primary selective hypoaldosteronism carrying three mutations in the aldosterone synthase (Cyp11b2) gene. 22465514 2012
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 GeneticVariation disease BEFREE A missense mutation (GGC[435Gly]-->AGC[Ser]) in exon 8 of the CYP11B2 gene inherited in Japanese patients with congenital hypoaldosteronism. 14614232 2003
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 AlteredExpression disease BEFREE Next, to clarify the mechanism of hypoaldosteronism in 17alpha-hydroxylase deficiency, we analysed the expression of aldosterone synthase (CYP11B2) messenger RNA and sequenced CYP11B2 in these patients. 11422109 2001
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 Biomarker disease CTD_human We conclude that aldosterone synthase deficiency represents an unusual cause of hyperreninemic hypoaldosteronism presenting in adult life, but it should be suspected if the past medical history is positive for failure to thrive in childhood or if the patient manifests no other recognized causes of hyperreninemic hypoaldosteronism. 11238478 2001
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 GeneticVariation disease BEFREE Mutations in CYP11B2 cause congenital hypoaldosteronism (aldosterone synthase deficiency) which is characterized by life-threatening salt loss, failure to thrive, hyponatraemia and hyperkalaemia in early infancy. 10559665 1999
Entrez Id: 1585
Gene Symbol: CYP11B2
CYP11B2
0.370 GeneticVariation disease BEFREE Homozygous deletion of arginine-173 in the CYP11B2 gene in a girl with congenital hypoaldosteronism. Corticosterone methyloxidase deficiency type II. 9838244 1998
Entrez Id: 51458
Gene Symbol: RHCG
RHCG
0.200 Therapeutic disease RGD Aldosterone requires vasopressin V1a receptors on intercalated cells to mediate acid-base homeostasis. 21415155 2011
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 Biomarker disease BEFREE The lack of pro-opiomelanocortin (POMC)-derived melanocortin peptides results in hypoadrenalism and severe obesity in both humans and rodents that is treatable with synthetic melanocortins. 30201275 2018
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 Biomarker disease BEFREE Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by severe glucocorticoid deficiency associated with failure of adrenal responsiveness to ACTH but no mineralocorticoid deficiency. 19795005 2009
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 Biomarker disease BEFREE Familial glucocorticoid deficiency (FGD), otherwise known as hereditary unresponsiveness to ACTH, is a rare autosomal recessive disease characterized by glucocorticoid deficiency in the absence of mineralocorticoid deficiency. 18059087 2008
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 GeneticVariation disease BEFREE We identified a novel homozygous frameshift (C6906del) mutation in POMC in a child of Turkish origin with severe obesity and hypoadrenalism. 16936203 2006
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 GeneticVariation disease BEFREE The functional loss of both alleles of the human pro-opiomelanocortin (POMC) gene leads to a very rare syndrome of hypoadrenalism, red hair and early-onset obesity. 12165561 2002
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 Biomarker disease BEFREE Mineralocorticoid deficiency preceded glucocorticoid deficiency which could be diagnosed through ACTH stimulation after the neonatal period. 10931108 2000
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 Biomarker disease BEFREE We have determined the 21-hydroxylase genotype in 197 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency and assessed phenotypic characteristics based on 1) genital status with respect to virilization in females, 2) ACTH stimulation tests to evaluate the secretion of androgens and 17-hydroxyprogesterone, and 3) salt deprivation tests to precisely describe the phenotype with respect to aldosterone deficiency and salt wasting. 7629224 1995
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.080 GeneticVariation disease BEFREE The syndrome of familial adrenocorticotropin (ACTH) unresponsiveness is a rare form of primary adrenal insufficiency, usually without mineralocorticoid deficiency. 7758515 1995
Entrez Id: 5972
Gene Symbol: REN
REN
0.040 Biomarker disease BEFREE Recently, we linked their urine sodium loss to a hypoaldosteronism at variance with an appropriate stimulation of the renin-angiotensin system. 28747362 2018
Entrez Id: 5972
Gene Symbol: REN
REN
0.040 Biomarker disease BEFREE The syndrome of apparent mineralocorticoid excess (AME) is an autosomal recessive disorder characterized by hypertension, hypokalemia, low renin, and hypoaldosteronism. 23329753 2012
Entrez Id: 5972
Gene Symbol: REN
REN
0.040 AlteredExpression disease BEFREE Mild disturbances in the renin-angiotensin-aldosterone axis were noted in four out of six patients, ranging from slightly elevated plasma renin levels to low aldosterone levels, although frank mineralocorticoid deficiency or electrolyte disturbance were not found. 19170705 2009
Entrez Id: 5972
Gene Symbol: REN
REN
0.040 AlteredExpression disease BEFREE Further endocrine evaluation revealed baseline hypoaldosteronism associated with elevated renin activity. 11874420 2002
Entrez Id: 1589
Gene Symbol: CYP21A2
CYP21A2
0.030 Biomarker disease BEFREE Congenital adrenal hyperplasia (CAH), CYP21A2 deficiency, results in cortisol and aldosterone deficiency and increased production of androgens, with a good genotype phenotype correlation. 24476073 2014
Entrez Id: 1589
Gene Symbol: CYP21A2
CYP21A2
0.030 GeneticVariation disease BEFREE Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is an autosomal recessive condition in which deletions or mutations of the cytochrome P450 21-hydroxylase gene cause glucocorticoid and often mineralocorticoid deficiency. 11919101 2002
Entrez Id: 1589
Gene Symbol: CYP21A2
CYP21A2
0.030 Biomarker disease BEFREE Lesions in the gene encoding the adrenal enzyme steroid 21-hydroxylase (P450c21) result in defective adrenal cortisol synthesis, often accompanied by aldosterone deficiency. 8478006 1993
Entrez Id: 190
Gene Symbol: NR0B1
NR0B1
0.020 GeneticVariation disease BEFREE NR0B1/DAX-1 mutations should be considered in male infants presenting with isolated hypoaldosteronism as first sign of adrenal insufficiency. 31164167 2019